OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 30, 2018
The company received a complete response letter from FDA in response to the biologics license application for a proposed trastuzumab biosimilar.
April 26, 2018
Proteus Digital Health is collaborating on a pipeline of digital, oral solid-dosage drugs for various therapies, including cardiovascular and oncology drugs, based on its first NDA, which used ingestible sensors in an antipsychotic treatment.
April 20, 2018
The new platform is expected to speed up cell line development.
April 19, 2018
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
April 18, 2018
INTERPHEX presents advances in pharmaceutical container filling, robotic handling, and serialization.
April 16, 2018
Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.
April 12, 2018
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
April 11, 2018
New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.